Healthcare expenses for treatment of acute myeloid leukemia-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Healthcare expenses for treatment of acute myeloid leukemia

Published:2019-06-13 Issue:8 Volume:12 Page:641-650
ISSN:1747-4086
Container-title:Expert Review of Hematology
language:en
Short-container-title:Expert Review of Hematology

Author:

Bewersdorf Jan Philipp¹^ORCID,Shallis Rory M.¹^ORCID,Wang Rong²³,Huntington Scott F.¹²,Perreault Sarah⁴,Ma Xiaomei²³,Zeidan Amer M.¹²

Affiliation:

1. Department of Internal Medicine, School of Medicine, Yale University, New Haven, CT, USA

2. Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center, Yale University, New Haven, CT, USA

3. Department of Chronic Disease Epidemiology, School of Public Health, Yale University, New Haven, CT, USA

4. Department of Pharmacy, Yale New Haven Hospital, New Haven, CT, USA

Funder

not funded

Publisher

Informa UK Limited

Subject

Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/17474086.2019.1627869

Reference58 articles.

1. Cancer statistics, 2018

2. Continued improvement in survival of acute myeloid leukemia patients: an application of the loss in expectation of life

3. Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with aFLT3Mutation

4. Enasidenib in mutant IDH2 relapsed or refractory acute myeloid leukemia

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A systematic review of health state utility values for older people with acute myeloid leukaemia;Quality of Life Research;2024-08-22

2. Real-world results of venetoclax combined with hypomethylating agents in young adults with relapsed/refractory acute myeloid leukemia;Hematology;2023-10-05

3. Treatment patterns and clinical outcomes in acute myeloid leukemia patients who are not eligible for intensive induction chemotherapy: A real-world study from Latin-America;Medicina y Laboratorio;2023-09-21

4. Economic burden during remission and after relapse among older patients with newly diagnosed acute myeloid leukemia without hematopoietic stem cell transplant: A retrospective study using the SEER-Medicare database;Leukemia Research;2023-09

5. Economic burden of acute myeloid leukemia on patients in a resource-limited tertiary hospital in the Philippines;Hematology, Transfusion and Cell Therapy;2023-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3